Xu Diyong 4
4 · Q32 Bio Inc. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Xu Diyong
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+12,767→ 12,767 totalExercise: $16.82Exp: 2034-03-24→ Common Stock (12,767 underlying)
Footnotes (2)
- [F1]One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.